|
Q3 FY2023
As of Feb 28, 2023
|
Q2 FY2023
As of Nov 30, 2022
|
Q1 FY2023
As of Aug 31, 2022
|
Q4 FY2022
As of May 31, 2022
|
Q3 FY2022
As of Feb 28, 2022
|
Q2 FY2022
As of Nov 30, 2021
|
Q1 FY2022
As of Aug 31, 2021
|
Q4 FY2021
As of May 31, 2021
|
Q3 FY2021
As of Feb 28, 2021
|
Q2 FY2021
As of Nov 30, 2020
|
Q1 FY2021
As of Aug 31, 2020
|
Q4 FY2020
As of May 31, 2020
|
Q3 FY2020
As of Feb 29, 2020
|
Q2 FY2020
As of Nov 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| CURRENT ASSETS: | ||||||||||||||
| Accounts receivable | ||||||||||||||
| Vendor deposits | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Inventory | ||||||||||||||
| Deposits | ||||||||||||||
| Prepaids and other current assets | ||||||||||||||
| Total current assets | ||||||||||||||
| Investments in equity securities, at cost | ||||||||||||||
| Equipment, net | ||||||||||||||
| Right to use asset | ||||||||||||||
| Cannabis licenses | ||||||||||||||
| Finite-lived intangible assets, net | ||||||||||||||
| Indefinite-lived intangible assets, net | ||||||||||||||
| Total non-current assets | ||||||||||||||
| Total Assets | ||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||
| Accounts payable | ||||||||||||||
| Payable for discontinued operations (Note 3) | ||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||
| Customer deposits | ||||||||||||||
| Payable to related parties | ||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||
| Accounts payable to related parties | ||||||||||||||
| Advances from related parties | ||||||||||||||
| Accrued interest payable | ||||||||||||||
| Accrued rent payable - related party | ||||||||||||||
| Lease liability - current portion | ||||||||||||||
| Put option liability | ||||||||||||||
| Put option liablility | ||||||||||||||
| Satellite note payable, net of discount | ||||||||||||||
| Diagonal convertible note payable | ||||||||||||||
| Convertible note payable - related party | ||||||||||||||
| Notes payable, net of discount | ||||||||||||||
| Other current liabilities | ||||||||||||||
| Total current liabilities | ||||||||||||||
| LONG-TERM LIABILITIES: | ||||||||||||||
| Payable to related parties for services | ||||||||||||||
| Total long-term liabilities | ||||||||||||||
| Accounts payable to related parties - long-term | ||||||||||||||
| Lease liability - long-term | ||||||||||||||
| Advance from non-related party | ||||||||||||||
| Accounts payable - long-term | ||||||||||||||
| Common stock payable | ||||||||||||||
| Payables to related parties - long-term | ||||||||||||||
| Accounts payable - long term | ||||||||||||||
| Lease liability - long term | ||||||||||||||
| Satellite note payable, net of discount – long term | ||||||||||||||
| Satellite note payable, note of discount – long term | ||||||||||||||
| Satellite note payable, net of discount - long term | ||||||||||||||
| Advances from related parties | ||||||||||||||
| Total long-term liabilities | ||||||||||||||
| Total Liabilities | ||||||||||||||
| Common stock, $0.0001 par value, 100,000,000 shares authorized; 44,854,737 and 33,574,436 shares issued and outstanding, respectively | ||||||||||||||
| Common stock subject to cancellation on dicontinued operations (1,300,000 shares) (Note 3) | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||
| Total Liabilities and Stockholders' Equity (Deficit) | ||||||||||||||
Loading...